M Rauchhaus

Summary

Affiliation: Imperial College
Country: UK

Publications

  1. ncbi The endotoxin-lipoprotein hypothesis
    M Rauchhaus
    Department of Clinical Cardiology, National Heart and Lung Institute, London, UK
    Lancet 356:930-3. 2000
  2. ncbi Plasma cytokine parameters and mortality in patients with chronic heart failure
    M Rauchhaus
    Clinical Cardiology, National Heart and Lung Institute, Royal Brompton Hospital, London, UK
    Circulation 102:3060-7. 2000
  3. ncbi Inflammatory cytokines and the possible immunological role for lipoproteins in chronic heart failure
    M Rauchhaus
    Department of Clinical Cardiology, Imperial College School of Medicine at the National Heart and Lung Institute, London, UK
    Int J Cardiol 76:125-33. 2000
  4. ncbi Uric acid in cachectic and noncachectic patients with chronic heart failure: relationship to leg vascular resistance
    W Doehner
    Clinical Cardiology, National Heart and Lung Institute, Imperial College School of Medicine, London, UK
    Am Heart J 141:792-9. 2001
  5. ncbi Insights into the pathogenesis of chronic heart failure: immune activation and cachexia
    S D Anker
    Department of Cardiac Medicine, National Heart and Lung Institute, London, UK
    Curr Opin Cardiol 14:211-6. 1999
  6. ncbi Origin of oscillatory kinetics of respiratory gas exchange in chronic heart failure
    D P Francis
    National Heart and Lung Institute, Imperial College of Science, Technology and Medicine, London, UK
    Circulation 100:1065-70. 1999
  7. ncbi Heart failure as a metabolic problem
    S D Anker
    Department of Cardiac Medicine, National Heart and Lung Institute, London, UK
    Eur J Heart Fail 1:127-31. 1999
  8. ncbi High tumour necrosis factor-alpha levels are associated with exercise intolerance and neurohormonal activation in chronic heart failure patients
    M Cicoira
    Department of Cardiac Medicine, National Heart and Lung Institute, London, UK
    Cytokine 15:80-6. 2001

Detail Information

Publications8

  1. ncbi The endotoxin-lipoprotein hypothesis
    M Rauchhaus
    Department of Clinical Cardiology, National Heart and Lung Institute, London, UK
    Lancet 356:930-3. 2000
    ..We also propose that, in patients with CHF, a non-lipid-lowering statin (with ancillary properties such as immune modulatory and anti-inflammatory actions) could be as effective or even more beneficial than a lipid-lowering statin...
  2. ncbi Plasma cytokine parameters and mortality in patients with chronic heart failure
    M Rauchhaus
    Clinical Cardiology, National Heart and Lung Institute, Royal Brompton Hospital, London, UK
    Circulation 102:3060-7. 2000
    ..Little is known about the prognostic importance of tumor necrosis factor-alpha (TNF-alpha), soluble TNF-receptor 1 and 2 (sTNF-R1/sTNF-R2), interleukin-6 (IL-6), and soluble CD14 receptors (sCD14) in CHF patients...
  3. ncbi Inflammatory cytokines and the possible immunological role for lipoproteins in chronic heart failure
    M Rauchhaus
    Department of Clinical Cardiology, Imperial College School of Medicine at the National Heart and Lung Institute, London, UK
    Int J Cardiol 76:125-33. 2000
    ....
  4. ncbi Uric acid in cachectic and noncachectic patients with chronic heart failure: relationship to leg vascular resistance
    W Doehner
    Clinical Cardiology, National Heart and Lung Institute, Imperial College School of Medicine, London, UK
    Am Heart J 141:792-9. 2001
    ..We aimed to study the relationship between serum uric acid levels and leg vascular resistance in patients with CHF with and without cachexia and in healthy control subjects...
  5. ncbi Insights into the pathogenesis of chronic heart failure: immune activation and cachexia
    S D Anker
    Department of Cardiac Medicine, National Heart and Lung Institute, London, UK
    Curr Opin Cardiol 14:211-6. 1999
    ..A complex catabolic-anabolic imbalance in different body systems may cause body wasting in patients with CHF...
  6. ncbi Origin of oscillatory kinetics of respiratory gas exchange in chronic heart failure
    D P Francis
    National Heart and Lung Institute, Imperial College of Science, Technology and Medicine, London, UK
    Circulation 100:1065-70. 1999
    ..This necessitates hypothesizing that PB is caused by a primary oscillation in tissue metabolism or in cardiac output...
  7. ncbi Heart failure as a metabolic problem
    S D Anker
    Department of Cardiac Medicine, National Heart and Lung Institute, London, UK
    Eur J Heart Fail 1:127-31. 1999
    ..Joint efforts of cardiologists, endocrinologists, and immunologists are required to develop therapeutic strategies able to improve the metabolic status of CHF patients...
  8. ncbi High tumour necrosis factor-alpha levels are associated with exercise intolerance and neurohormonal activation in chronic heart failure patients
    M Cicoira
    Department of Cardiac Medicine, National Heart and Lung Institute, London, UK
    Cytokine 15:80-6. 2001
    ..In CHF patients only the highest levels of TNF are associated with poor functional status and neurohormonal activation. This group of patients may represent the appropriate target population for TNF antagonism...